Chief Executive Officer and Co-Founder, Crystal Research Associates LLC
Mr. Kraws ranks in the top ten analysts for pharmaceutical stock performance in the world, and Starmine and Zacks have both ranked him as number one stock picker for pharmaceuticals. His experience includes Senior Pharmeceutical Analyst at Evern Securities, Asea Brown Boveri, Nationsbanc Montgomery Securities, BT Alex Brown & Sons and The Buckingham Research Group Incorporated.
He holds an MBA from Cornell University and a B.S. degree from State University of New York-Buffalo.
